|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM182241645 |
003 |
DE-627 |
005 |
20231223162547.0 |
007 |
cr uuu---uuuuu |
008 |
231223s2008 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2008.07.006
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0608.xml
|
035 |
|
|
|a (DE-627)NLM182241645
|
035 |
|
|
|a (NLM)18771958
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Li, Hsing-Hui
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Interleukin-20 targets renal mesangial cells and is associated with lupus nephritis
|
264 |
|
1 |
|c 2008
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 06.11.2008
|
500 |
|
|
|a Date Revised 11.12.2018
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Lupus nephritis is one manifestation of systemic lupus erythematosus (SLE). Interleukin (IL)-10 is involved in the pathogenesis of SLE. To determine whether IL-20, a member of the IL-10 family, is associated with lupus nephritis, we analyzed the expression of IL-20 and its receptors in mesangial cells derived from SLE-prone, NZB/W, and DBA/W mice. IL-20 and its receptors were upregulated in mesangial cells from NZB/W mice. Incubating IL-20 with mesangial cells upregulated the transcripts of CCL2 (MCP-1), CCL5 (RANTES), CXCL10 (IP-10), IL-6, iNOS, and ROS, all of which are involved in the pathogenesis of lupus nephritis. IL-20 specifically activated the downstream signal ERK 1/2. We also detected human IL-20 protein in both mesangial cells and inflammatory cells in kidney biopsies of patients with lupus nephritis. Our results reveal the novel effects of IL-20 on mesangial cells and its association with lupus nephritis
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Chemokines
|2 NLM
|
650 |
|
7 |
|a Cytokines
|2 NLM
|
650 |
|
7 |
|a Interleukins
|2 NLM
|
650 |
|
7 |
|a Reactive Oxygen Species
|2 NLM
|
650 |
|
7 |
|a Nitric Oxide Synthase Type II
|2 NLM
|
650 |
|
7 |
|a EC 1.14.13.39
|2 NLM
|
650 |
|
7 |
|a Extracellular Signal-Regulated MAP Kinases
|2 NLM
|
650 |
|
7 |
|a EC 2.7.11.24
|2 NLM
|
650 |
|
7 |
|a interleukin 20
|2 NLM
|
650 |
|
7 |
|a U91R7IMG8U
|2 NLM
|
700 |
1 |
|
|a Cheng, He-Hsiung
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sun, Kuang-Hui
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wei, Chi-Chen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Li, Chien-Feng
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chen, Wen-Chung
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wu, Wen-Mein
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chang, Ming-Shi
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 129(2008), 2 vom: 19. Nov., Seite 277-85
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:129
|g year:2008
|g number:2
|g day:19
|g month:11
|g pages:277-85
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2008.07.006
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 129
|j 2008
|e 2
|b 19
|c 11
|h 277-85
|